Genpact (G) Beat Estimates And Raised Guidance, Is The Stock Still Undervalued?

Genpact (G) put fresh numbers on the table in its latest third quarter update, reporting earnings that topped Wall Street expectations and raising full year guidance after solid revenue and margin performance.

Recent trading shows that investors have reacted positively to Genpact’s update, with a 30 day share price return of 22.87% and a 90 day gain of 19.86% from a latest share price of US$41.10, even though the year to date share price return is still down 10.48% and the five year total shareholder return is also lower by 13.51%.

Scan how Genpact’s earnings surprise compares with other service and AI exposed companies by reviewing our hand picked 21 high quality undiscovered gems, which have been screening well on fundamentals and momentum.

Genpact’s sharp rebound and guidance lift point to a business that looks healthier than its earlier share price suggested, yet sentiment often runs ahead of the numbers. The key question is how far the current valuation already reflects this reset.

Most Popular Narrative: 2.6% Undervalued

On Simply Wall St’s most followed narrative, Genpact’s fair value sits at $42.18 against a last close of $41.10. The spread is small, so the focus shifts to what could move that gap wider or close it.

The rising share of annuitized, non FTE and outcome based contracts, with non FTE revenue surpassing 50% of total revenue in Q2 2026 and more than 70% of ATS revenue both annuitized and non FTE, increases the potential for more recurring revenue and steadier earnings over time.

See why 19 investors see Genpact as 3% undervalued.

Result: Fair Value of $42.18 (UNDERVALUED)

Still, Genpact’s effort to exit lower value content and contact center contracts could weigh on reported growth if Advanced Technology Solutions and agentic deals ramp more slowly than analysts expect.

Find out about the key risks to this Genpact narrative.

Next Steps

Mixed messages in the Genpact story so far, with both concern and optimism in play, mean the next step is yours, not the market’s. Act quickly, review the full spread of risks and potential upsides, then decide where you land after weighing the 5 key rewards and 1 important warning sign.

Looking for more Genpact-sized investment ideas?

If Genpact has sharpened your focus, do not stop here. Use the Simply Wall St screener to spot other opportunities before they move without you.

• Pinpoint companies with strong cash flows and valuation support by scanning our 42 high quality undervalued stocks for ideas that might fit a disciplined checklist.
• Strengthen your income watchlist by reviewing a focused group of high yielding stocks through the 6 dividend fortresses that filters for payout resilience.
• Prioritize capital protection by filtering for stocks with steadier risk profiles using the 32 resilient stocks with low risk scores which is geared toward resilience minded investors.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com